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Stem cells are unique in that they possess totipotent, pluripotent, or multipotent 
differentiation capabilities and can also self-renew. Stem cells are in either a state of self-
renewal or differentiation, but never both. If we are able to gain a full understanding of the 
underlying mechanisms that allow stem cells to remain self-renewing and multipotent, we 
will better be able to control the fate of cells, ultimately allowing stem cells to be used to 
their full capabilities in regenerative medicine. My research focuses on MED12 and its 
effects on Notch signaling. Here we describe the expression profile and activity of MED12, 
Notch1, and Notch3 in self-renewing human adipose stem cells and determine the impact 
that MED12 knockdown has on Notch1 and Notch3 expression and activity in self 
renewing hASC’s. We hypothesized that MED12 has a critical role in regulating 
transcription, while Notch signaling has a role in directing cell fate commitment. We 
observed that the knockdown of MED12 in hASCs has no effect on the protein expression 
of Notch1. We also observed that the knockdown of Notch3 does reduce the amount of 
MED12 transcript expressed in hASCs. To date, our data suggests that MED12 has no 
effect on Notch1 expression but does affect Notch3 expression. Also, the knockdown of 
Notch3 directly effects MED12 transcript. This data indicates a unique role for MED12 
and a relationship with Notch3 in regulating cell state, leading us one step closer to 
realizing the clinical potential of these cells and using them in novel cell-based and tissue 
engineering therapies. 
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1.1 Stem Cells 
Stem cells are unique in that they possess totipotent, pluripotent, or multipotent 
differentiation capabilities and can also self-renew (Miana and Prieto González, 2018). 
Totipotent stem cells (zygote) have the ability to differentiate into any cell in the body as 
well as extra embryonic tissues, including placenta (Sobhani et al., 2017). Pluripotent stem 
cells (embryonic stem cells and induced pluripotent stem cells) have the same abilities to 
form an adult organism but unlike totipotent stem cells, lack the ability to form extra 
embryonic tissue (Sobhani et al., 2017). Multipotent stem cells (i.e adult stem cells) are the 
most limited of the three types of stem cells, as they can only differentiate into cells of a 
defined lineage (Sobhani et al., 2017). Although most limited in their differentiation 
potential, multipotent adult stem cells possess the most therapeutic potential as they can be 
used in an autologous manner and offer unique immunomodulatory properties in additional 
to their differentiation potential. 
Mesenchymal stem cells have the ability to differentiate into multiple cell types of 
the mesodermal lineage such as osteocytes, chondrocytes, myocytes, and adipocytes 
(Daniel E Shumer, Natalie J Nokoff, 2017) (Figure 1-1). Human mesenchymal stem cells 
are found in bone marrow, adipose tissue, amniotic fluid, and the umbilical cord (NITKIN 




isolated, they are also not accompanied by the public controversies that are associated with 
embryonic stem cells, making them a more acceptable source for research and clinical 
application. When using these cells for regenerative medicine, bone marrow-derived 
mesenchymal stem cells have been at the forefront of current studies due to their long 
history of clinical usage in the form of bone marrow transplants (Sobhani et al., 2017). 
Despite their clinical advantages, in order to obtain human bone marrow-derived 
mesenchymal stem cells, an invasive and sometimes painful procedure needs to be 
performed, making them a challenging cell source for additional therapeutic usage. 
Human adipose stem cells offer an alternative to bone marrow-derived 
mesenchymal stem cells that are both easily accessible and abundant using minimally 
invasive procedures (Miana and Prieto González, 2018). Offering much of the same 
clinical potential as bone marrow-derived cells, adipose stem cells are derived from adipose 
tissue through subcutaneous lipoaspiration, a less invasive and less painful harvesting 
protocol. Human adipose stem cells are currently being used in cancer treatment centers 
and in multiple clinical trials. The clinical trials include attempts to repopulate areas of the 
cardiac muscle after a heart attack in both animal models and humans and using the 
multipotency of hASC’s as a regenerative treatment to counteract different conditions such 






Figure 1-1: Gene expression is controlled by a complex regulatory network.  
Environmental stimuli initially activate signal transduction pathways. Once signaling 
components are activated, they can directly affect transcription factors and chromatin 
modifiers to initiate or inhibit transcription. When a gene is transcribed, transcription 
factors are activated and translocated into the nucleus of a cell to initiate transcription. If a 
gene target is repressed, chromatin is modified and condensed to prevent transcription. 
 
1.1.1 Notch Signaling 
The Notch signaling pathway is an evolutionarily conserved cell fate determination 
pathway that controls cell differentiation, proliferation, and apoptosis (Nueda et al., 2018). 
The evolutionary conserved Notch signaling pathway functions as a mediator of short-
range cell-cell communication (Kopan and Ilagan, 2009). The ectodomain of a Notch 
receptor can read information about the state of neighboring cells as it recognizes ligands 
that are expressed at their surface, whereas its intracellular domain, upon activation, acts 
as a transcriptional regulator that adjusts cell fate according to the state of the neighboring 




The Notch signaling pathway in humans consists of five canonical transmembrane 
Notch ligands Delta-like ligand 1 (DLL1), DLL3, DLL4, Jagged 1, Jagged 2, and four 
transmembrane Notch receptors: Notch1, Notch2, Notch3, and Notch4 (Nueda et al., 
2018). Each Notch receptor has three functional domains: The Notch extracellular domain, 
the Notch transmembrane domain, and the Notch intracellular domain (NICD).  Finally, 
there are two forms of the Notch signaling pathway: the NICD /CSL‑dependent 
transcription of Notch target genes known as the canonical Notch signaling cascade, and 
the CSL‑independent cellular responses, referred to as the non‑canonical Notch signaling 
cascade. The multiple components of the pathway and the different signaling mechanisms 
make this one of the more complex biological pathways (Katoh and Katoh, 2020). 
The Notch signaling pathway directly couples events at the cell membrane with the 
regulation of transcription. Through the canonical pathway, receptors on a given cell are 
activated in a contact dependent manner by cell surface ligands (Jagged1-2, DLL1, DLL3, 
DLL4) from neighboring cells in a process known as trans-activation. Although ligands 
expressed by neighboring cells have a trans-activation ability, ligands expressed in cis may 
have an inhibitory function, which acts to maintain the state of the signal-sending cell, 
keeping them from becoming signal-receiving cells. Once trans-activation is initiated, it 
leads to a structural change in the Notch receptor that exposes the buried cleavage site (S2) 
making it available to the metalloproteases of the ADAM/TACE family. Cleavage at this 
S2 site then generates a membrane-tethered form of Notch that is further cleaved by γ-
secretase complex to release the Notch intracellular domain (NICD).  The NICD is then 




confirmed to have a role in human development and disease making it a significant factor 
in the study of stem cells and determination of cell fate (Henrique and Schweisguth, 2019). 
Stem cells are able to both clone themselves (self-renew) or differentiate into 
multiple cell types depending on how gene expression is regulated. Stem cell fate can be 
regulated by altering the function and expression of the general transcription factors 
(GTFs) that assemble the transcription preinitiation complex (PIC) on gene promoters. 
GTFs also assemble activators and repressors that bind to gene regulatory elements located 
upstream or downstream of promoters, and the essential coactivator of cell type-specific 
genes like the Mediator complex. The fate of any stem cell is ultimately determined by 
regulating the transcription of specific genes, a feature largely facilitated by the Mediator 









1.1.2 Mediator Complex 
The Mediator complex plays a vital role in the regulation of cell-type specific 
transcription in eukaryotic cells. The Mediator complex is a large protein complex of 30 
subunits arranged in four modules: head, middle, tail, and kinase (CDK8) (Figure 1-3) 
(Park et al., 2018). The head and middle modules contain the most highly conserved 
subunits and maintain cell viability and overall gene expression, while the tail recruit’s 
specific transcription factors to direct and maintain lineage commitment. Indicative of its 
functional versatility, Mediator is implicated in regulating at least some aspect of many 
fundamental processes involved in transcription, including transcription initiation, 
transcription elongation, chromatin architecture and enhancer-promoter gene looping 
(Allen and Taatjes, 2015). In the Mediator complex, CDK8 attaches to Mediator core 
complex and activates or suppresses transcription via RNA polymerase II (Park et al., 
2018). The kinase module also functions independently of the Mediator complex. RNAPII, 
TFIIH, histone H3, and MED13 have all been listed as substrates for the CDK8 kinase 
(Knuesel et al., 2009). CDK8 is considered both an oncogene and a tumor suppressor and 
promotes cell growth via the serum response pathway (Fant and Taatjes, 2019). In stem 
cells, Mediator is the factor that controls regulation of transcription and in controlling 
transcription, Mediator controls the fate of stem cells. CDK8 is a part of the 30 subunit 
Mediator (MED) complex, which acts as a molecular bridge to mediate transduction of 
regulatory signals (Leach and Leach, 2017). It completes this task by using a module that 
consists of Cyclin C, Med12, and Med13. The Mediator complex is composed of multiple 
important factors that are necessary for the regulation of transcription in eukaryotic cells 







 Stem cells are in either a state of self-renewal or differentiation, but never at the 
same time. If we are able to gain a full understanding of the underlying mechanisms that 
allow stem cells to remain self-renewing and multipotent, we will better be able to control 
the fate of cells, which is the key to regenerative medicine becoming a reality. With 
conditions such as degenerative eye disease, stem cell treatment has the potential to replace 
lost neurons, restore neural circuits, and even induce the growth of new connections in the 
eye’s neural pathways (Mead et al., 2015).  If we can extend this to other conditions like 
Muscular dystrophies (MD) and Parkinson’s disease, we will be able to make a significant 
change to the medical world by not only stopping the effects of these degenerative diseases, 
but also reversing the damage that the disease has already caused. 
The central dogma of molecular biology describes the process of transcribing DNA 
to RNA and translating RNA to proteins. Transcription is a vital process in all living cells 
and is ultimately what determines the fate of a cell. If we can gain an understanding of the 
mechanisms surrounding transcriptional regulation in adipose stem cells, we can control 




the fate of the cell to stop stem cells from becoming cancerous and direct their fate for use 
in cell-based therapies, tissue engineering, and regenerative medicine.   
Both Mediator and the Notch signaling pathway work in unison to control the fate 
of ASCs through the careful regulation of gene expression. Although critical to controlling 
healthy tissue, the relationship between Mediator and Notch remains poorly defined.  A 
recent study suggests a possible influence of MED12 on Notch signaling in chronic 
lymphocytic leukemia cells (Wu et al., 2017) found that in order to activate or repress 
transcription, CDK8 is recruited to the MED12 subunit. Once in place, CDK8 interacts 
with the rest of the kinase module, Cyclin C, MED12, and MED13, causing the complex 
to activate or suppress transcription by RNA Polymerase II. In this study, MED12 effects 
Notch signaling by functioning as an activator of Cyclin C/CDK8. If MED12 is mutated 
or absent, it does not interact with the CDK8 kinase and the Notch Intracellular Domain 
(NICD) is not phosphorylated, leading to an increase in Notch activity and transcription 
activation. This aberrant regulation and absence of control leads to the activation of Notch, 
which causes uncontrolled cell differentiation or proliferation. This recent report indicates 
the need for further investigation in order to better understand the interaction and 
relationship of these proteins in controlling hASC self-renewal and move stem cell research 








2.1 Cell culture  
2.1.1 Thawing of cells.  
Human adipose stem cells (Obatala #70926) were removed from liquid nitrogen 
and thawed in a 37˚C water bath. Cells were transferred into a 15 mL conical containing 
4mL of pre-warmed Complete Culture Media (CCM) composed of 203.75mL of Minimum 
Essential Medium, 41.25mL of Fetal Bovine Serum, 2.5mL of L-Glutamine, and 2.5mL of 
Penicillin-Streptomycin. Cells were centrifuged at 1500 RPM for 8 minutes. The 
supernatant was removed, and cells were resuspended in 1mL of CCM. Cells were plated 
the cells onto 10cm tissue culture plates with 9mL of CCM. Media was changed 24 hours 
after the initial thaw, and every 48 hours after until cell confluency reached 70-80%.  
2.1.2 Passaging of cells.  
When the cells reached 70-80% confluence they were rinsed with pre-warmed 
phosphate buffered saline (PBS). 3mL of Trypsin was added to the plate and cells were 
incubated for 3 minutes at 37˚C. 6mL of CCM (or double the amount of trypsin) was then 
added to the plate and the cells were collected into a conical tube for centrifugation at 1500 
RPM for 10 minutes. Supernatant was aspirated and cells were resuspended in 1mL of pre-
warmed CCM. Cells were counted by mixing 20µL of trypan blue and 20µL of the cell 




FL hemocytometer and the slide was inserted into the cell counter. After cells were 
counted, they were then passaged onto 6cm plates. (Table 2-1) 
 
Table 2-1: Number of cells plated onto each plate. 
Plate size Number of cells seeded 
10cm plate 100,000 cells 
6cm plate 45,000 cells 
6-well plate 20,000 cells per well 
 
2.1.3 Transfection of cells.  
When the cells reached 20-40% confluency they were transfected with a control 
siRNA or a target gene siRNA.  Cells were transfected using RNAi Max Lipofectamine 
following manufacturer’s protocol.  Cells were incubated at 37˚C overnight and the next 
day media was replaced with pre-warmed CCM. Media was changed 24 hours after the 
transfection using CCM and RNA or protein was collected 72 hours after the transfection. 
2.2 RNA 
2.2.1 RNA collection.  
72 hours after the transfection, plates were rinsed with PBS and RNA was collected 
in 500µL of Trizol /6cm plate. Plates were gently scraped using a cell scraper and the 
solution was collected and stored in a -80˚C freezer.  
2.2.2 RNA extraction.  
Trizol samples was thawed at room temperature and 100µL of chloroform was 




incubate at room temperature for 3 minutes. Once the incubation was complete, the samples 
were centrifuged at 4˚C at 12000G and the colorless aqueous supernatant was removed and 
placed into a new Eppendorf tube. 5µL of glycogen along with 250µL of 100% isopropyl 
was added to each sample and each tube was inverted 3 times before it was left to incubate 
at room temperature for 10 minutes. Samples were then centrifuged at 4˚C at 12000G for 
10 minutes. The liquid supernatant was removed leaving only the RNA pellet. 1mL of 75% 
ethanol was added to the pellet and then vortexed to wash the pellet. The samples were 
then centrifuged for 5 minutes at 4˚C at 7500G. After the samples were centrifuged, the 
liquid supernatant was removed and the pellet was allowed to air dry, before 30µL of 
nuclease free water was added to RNA pellet. RNA was quantified to assess concentration 
and purity using the BioTek plate reader. The Gen5 Microplate Reader and Imager 
Software was used to analyze the data. 
2.2.3 cDNA synthesis 
cDNA was synthesized for each sample using 1 g of RNA and qScript cDNA 
supermix following manufacturer protocol. 
2.3 RT-PCR 
2.3.1 Endpoint RT-PCR.  
Primers (Table 2-2) and quality of cDNA were confirmed by endpoint RT-PCR using 









Table 2-2: Primer list  




















































99 60 30 
 
2.3.2 Quantitative reverse transcriptase PCR (qRT-PCR) 
qRT-PCR was performed using Power SYBR® Green PCR Master Mix and run 
using an Applied Biosystems StepOne Plus machine. Gapdh was used for normalization of 





2.4 Protein analysis 
2.4.1 Protein extraction and collection.  
When cells reached 70-80% confluency plates were rinsed with cold PBS. Cells 
were collected in lysis solution composed of RIPA buffer and protease inhibitor and 
transferred into Eppendorf tubes where they maintained constant agitation for 30 minutes 
at 4˚C. They were then centrifuged at 12000 RPM for 20minutes at 4˚C and the supernatant 
was transferred into a new Eppendorf tube.  
2.4.2 Protein concentration.  
Protein concentrations were measured using Bio-Rad Protein Assay Dye Reagent 
Concentrate following manufacturer's protocol. Absorbance was measured at a wavelength 
of 595 nm.  
2.4.3 Western blots 
 Protein samples were boiled and loaded into a 4-15% polyacrylamide gel based off of the 
Bradford assay results. Proteins were transferred on a Trans-Blot Turbo Mini PVDF 
Transfer using the Bio-Rad Trans-Blot Turbo Transfer System. The membranes were then 
blocked using a 5% blocking buffer composed of nonfat dry milk and TBST, then probed 
overnight with a primary antibody (Table 2-3). The membranes were then washed with 
TBST and probed with a secondary antibody for 60 minutes. After being washed, the 
membranes were then imaged with Bio-Rad clarity western ECL substrate and analyzed 







Table 2-3: Antibody list 
Antibody Dilution Company Catalog # 
MED12 1:1000 Bethyl A3000-774A 
Notch1 1:1000 Proteintech 20687-I-AP 
Notch3 1:1000 Cell signaling 5276S 
GAPDH 1:3000 abcam Ab9485 
Goat pAb to Rb IgG 
(HRP) 










Stem cells are unique in that they have the ability to differentiate and self-renew. 
Human adipose stem cells are a multipotent stem cell that possess therapeutic potential to 
treat multiple diseases and to help in regenerative medicine. If we are able to gain a better 
understanding of how we can control the fate of hASCs, this will allow stem cells to be 
used to their full potential in regenerative medicine. Here we seek to gain an understanding 
of hASCs by focusing on the Mediator complex and its effects on Notch signaling. 
Mediator is highly conserved in eukaryotic cells and directly controls transcription by 
interacting with signaling pathways like Notch. 
The Mediator complex plays a vital role in the regulation of cell-type transcription 
in eukaryotic cells (Straub, Venigalla and Newman, 2020). There are four modules of the 
Mediator complex: the head, middle, tail, and the kinase. Our focus is on the kinase module 
that consist of CDK8, Cyclin C, MED12, and MED13 (Park et al., 2018). We are 
specifically interested in MED12 and its role in regulating and controlling transcription in 
hASCs as MED12 is a critical part of the Mediator complex implicated in a number of 
human developmental defects and disease. Similarly, The Notch signaling pathway is an 
essential regulatory pathway in development, cell differentiation, proliferation, and 




In this chapter I will discuss how MED12 effects Notch1 and Notch3 in hASCs. 
We report on the expression and activity of MED12, Notch1, and Notch3 in self-renewing 
human adipose stem cells and determine the impact that MED12 knockdown has on Notch1 
and Notch3 expression and activity in self-renewing hASC’s. We hypothesized that 
MED12 has a critical role in regulating transcription, while Notch signaling has a role in 
directing cell fate commitment. We observed that the knockdown of MED12 in hASCs has 
no effect on the protein expression of Notch1. We also observed that the knockdown of 
Notch3 does reduce the amount of MED12 transcript expressed in hASCs. To date our data 
suggests that MED12 has no effect on Notch1 expression but does affect Notch3 
expression. In addition, the knockdown of Notch3 directly effects MED12 transcript. This 
data indicates a unique role for MED12 and a relationship with Notch3 in regulating cell 
state, leading us one step closer to realizing the clinical potential of these cells and using 
them in novel cell-based and tissue engineering therapies. 
3.2 Results 
MED12 KD has no effect on Notch1 in self-renewing hASCs   
In order to understand the influence of the Mediator complex, specifically MED12 
on the highly conserved Notch signaling pathway we transfected hASCs with MED12 
siRNA so that we could observe how the transfections affected Notch1. MED12 levels 
were decreased in cell culture via siRNA transfections and the knockdowns were validated 
using qRT-PCR and western blot. MED12 transcript was significantly reduced in 
comparison to negative controls while there was no significant effect on the levels of 
Notch1 transcript (Figure 3-1). In addition, MED12 protein levels were significantly 




(Figure 3-2). Although both MED12 and Notch1 have a role in determining cell state, this 













Figure 3-2: MED12 knockdown has no effect on Notch1 protein levels. Protein 
expression levels of hASCs transfected with MED12 siRNA via Western blot. (Left) The 
MED12 knockdown was validated while the identification of Notch1 was unsuccessful. 
ImageJ data showing the MED12 knockdown Western blot quantified using ImageJ 
software. Western blot was normalized to GAPDH. P values were calculated with T Test, 
N=2. (Right) 
 
Figure 3-1: MED12 knockdown leads to decreased Notch1 transcript. MED12 
siRNA effectively knockdowns MED12 transcript and diminishes expression of Notch1. 
Transcript levels of MED12 (left) and Notch1 (right) in hASCs transfected with MED12 
siRNA analyzed via qRT-PCR. There was not a significant reduction in the Notch1 
transcript levels. Data was normalized to GAPDH. P values were calculated with T Test, 
n=2. 
P value= .0000325 P value= 0.025110258 





MED12 KD does affect Notch3 expression in self-renewing hASCs 
 In continuation of trying to understand the influence of the Mediator complex, 
specifically MED12 on the highly conserved Notch signaling pathway hASCs were 
transfected with MED12 siRNA so that we could observe how the knockdown of MED12 
affected Notch3 expression and activity. MED12 levels were decreased in cell culture via 
siRNA transfections and the knockdowns were validated using qRT-PCR and western blot. 
MED12 transcript was significantly reduced in comparison to negative controls and there 
was also a significant reduction in the Notch3 transcript levels (Figure 3-3). The MED12 
protein levels were significantly reduced while there was an increase in full length Notch3 
protein, and a decrease in cleaved (activated) Notch3 protein (Figure 3-3)(Figure 3-4). 
Granted, we know that MED12 and Notch3 have a role in determining cell state, this data 




Figure 3-3: MED12 knockdown leads to decreased Notch3 transcript and an increase 
in full length Notch3 and a decrease in cleaved Notch3. Transcript levels in hASCs 
transfected with MED12 siRNA analyzed via qRT-PCR. The MED12 knockdown was 
validated (Figure 3-1). There was a significant reduction in the Notch3 transcript levels. 
Data was normalized to GAPDH. P values were calculated with T Test, N=2. (Left) Protein 
expression levels of hASCs transfected with MED12 siRNA via Western blot. The MED12 




knockdown was validated while the knockdown caused an increase in full length Notch3 
and a decrease in cleaved Notch3. (Right) 
 
 
Figure 3-4: MED12 knockdown effects on Notch3 protein levels. ImageJ analysis of 
MED12 knockdown Western blot effects on Notch3.  Western blot quantified using ImageJ 
software. Western blot was normalized to GAPDH. P values were calculated with T Test, 
N=2. 
 
Notch1 KD has no effect on MED12 in self-renewing hASCs 
 After it was determined that the knockdown of MED12 did not have any significant 
effect on Notch1 transcript or protein, results were confirmed by transfecting cells with 
Notch1 siRNA to determine if it had any effect on MED12 transcript or protein. Notch1 
levels were decreased in cell culture via siRNA transfections and the knockdowns were 
validated using qRT-PCR and western blot. Notch1 transcript was significantly reduced in 
comparison to negative controls and there was not a significant reduction in the MED12 
transcript levels nor protein levels (Figure 3-5)(Figure 3-6). This data is confirmation of 
what we had already observed, that although both MED12 and Notch1 have a role in 
determining cell state, Notch1 is not responsible for the regulation of MED12 transcript 







Figure 3-5: Notch1 knockdown has no effect on MED12 transcript. The Notch1 
knockdown was validated. Transcript levels in hASCs transfected with Notch1 siRNA 
analyzed via qRT-PCR. There was not a significant reduction in the MED12 transcript 
levels. Data was normalized to GAPDH. P values were calculated with T Test, N=2. 
 
 
Figure 3-6: Notch1 knockdown has no effect on MED12 protein levels. Protein 
expression levels of hASCs transfected with Notch1 siRNA via Western blot. MED12 was 
not affected by the Notch1 knockdown, while the identification of Notch1 was 
unsuccessful 
 
Notch3 KD does affect MED12 in self-renewing hASCs 
 Since it was determined that the knockdown of MED12 did significantly affect 
Notch3 transcript and protein, we completed the transfection of Notch3 to determine if it 
had any effect on MED12 transcript or protein. Notch3 levels were decreased in cell culture 





via siRNA transfections and the knockdowns were validated using qRT-PCR and western 
blot. Notch3 transcript was significantly reduced in comparison to negative controls and 
there was also a significant reduction in the MED12 transcript levels (Figure 3-7). The 
Notch3 protein levels were significantly reduced while there was a decrease in MED12 
protein levels (Figure 3-8)(Figure 3-9). The data observed shows that Notch3 regulates 
MED12 transcript and expression. This data combined with the data found in relation to 
MED12 and how it regulates Notch3 transcript and expression shows that MED12 and 




Figure 3-7: Notch3 knockdown leads to reduction in MED12 transcript.  Transcript 
levels in hASCs transfected with Notch3 siRNA analyzed via qRT- PCR. The Notch3 
knockdown was validated. There was a significant reduction in the MED12 transcript 










Figure 3-8: Notch3 knockdown leads to reduction in MED12 protein levels. Protein 
expression levels of hASCs transfected with Notch3 siRNA via Western blot. The Notch3 
knockdown was validated while the Notch3 knockdown had a slight effect on MED12 




Figure 3-9: Notch3 knockdown leads to reduction in MED12 protein levels. ImageJ 
analysis of a Notch3 knockdown effects on MED12. Western blot quantified using ImageJ 








MED12 KD effects on Notch signaling conical pathway ligands in self renewing hASCs 
 The data showed that after a MED12 knockdown in hASCs Notch1 transcript and 
protein levels were not affected, while Notch3 transcript and protein levels were 
significantly affected. The next step was to take a more focused look at the Notch signaling 
pathway and to see which of the Notch signaling conical pathway ligands, specifically 
Jagged1 and Jagged2, were affected by a MED12 knockdown. MED12 levels were 
decreased in cell culture via siRNA transfections and the knockdowns were validated using 
qRT-PCR. MED12 transcript was significantly reduced in comparison to negative controls 
and there was a slight increase in Jagged1 and Jagged2 transcript, but neither were 
significantly affected (Figure 3-10). This data suggests that neither Jagged1 nor Jagged2 




Figure 3-10: MED12 knockdown leads to increase in both Jagged1 and Jagged2 
transcript. Transcript expression levels of hASCs transfected with MED12 siRNA 
analyzed via qRT-PCR. The MED12 knockdown was validated while Jagged1 and Jagged2 
expression levels slightly increased but neither were significant. Data was normalized to 
GAPDH.  
 






After completing the knockdown of MED12 in hASCs and observing both Notch1 
and Notch3 transcript expression and protein levels, the results indicate that Notch1 does 
not have an active role in keeping the cells in the self-renewing state. The transcript levels 
and protein levels were low in the negative control samples and were not significantly 
affected by the MED12 knockdown. However, the data suggest that after the MED12 
knockdown, Notch3 transcript and protein levels were significantly affected. The transcript 
expression data shows that Notch3 was reduced after the MED12 knockdown. The protein 
levels of Notch3 after the MED12 knockdown showed that full length Notch3 increased 
while cleaved or activated Notch3 levels decreased.  When observing how the canonical 
pathway, specifically Jagged1 and Jagged2, of the Notch signaling pathway was affected 
by the MED12 knockdown, the data shows that neither Jagged1 nor Jagged2 transcript was 






CONCLUSIONS AND FUTURE WORK 
 
4.1 Conclusions 
At the start of our research, we hypothesized that MED12 has a critical role in 
regulating transcription, and directly effects the Notch signaling pathway and therefore cell 
fate commitment. After completing countless experiments where either siRNAs targeting 
MED12, Notch1, or Notch3 were transfected into hASCs, the data suggest that Notch1 
does not have an active role in directing cell fate. Both Notch1 transcript (Figure 3-1) and 
protein levels (Figure 3-2)were unaffected by the MED12 knockdown and when Notch1 
was knocked down, neither MED12 transcript (Figure 3-5) nor protein levels (Figure 3-6 
Figure 3-6) were affected. This suggest that Notch1 does not have an active role in 
regulating these mechanisms and may not have a role in hASC self-renewal. Next, we 
observed how Notch3 was affected by the MED12 knockdown. We were able to show that 
Notch3 transcript levels (Figure 3-3) were significantly reduced, while the levels of full 
length Notch3 protein (Figure 3-4) increased and the cleaved (activated) form of Notch3 
decreased. This observation suggests that MED12 has an active role in the regulation and 
activation of Notch3 in hASCs. The influence of diminished expression of MED12 on 
Notch3 lead us to knockdown Notch3 to determine what impact that might have on MED12 
expression. These results showed that after a Notch3 knockdown in hASCs, MED12 




similar trend (Figure 3-8, Figure 3-9). This data does not completely support our initial 
hypothesis that that MED12 has a critical role in regulating transcription by directly 
influencing the Notch signaling pathway, but it does suggest that MED12 and Notch3 work 
together in some way to regulate hASCs self-renewal. 
With the data that we have accumulated through multiple assays, we have 
contributed critical information that will aid in moving closer to an ability to control and 
manipulate hASCs for research and clinical applications. To date there is little literature on 
the relationship between Notch signaling and the Mediator complex. Some more recently 
studies did observe the effects on Notch1 after MED12 was mutated in chronic 
lymphocytic leukemia cells but other than that one instance, there is no literature linking 
the two (Wu et al., 2017). What I have completed while working in the lab starts to fill a 
much-needed gap in the literature that links Notch signaling and the Mediator complex in 
regulating hASC self-renewal.   
We are currently in the process of furthering this research by investigating how the 
canonical Notch transmembrane Delta-like ligands are affected by the MED12 
knockdown. We have started this work and have qRT-PCR data where we observe changes 
in Jagged1 and Jagged 2 expression following a MED12 knockdown (Figure 3-10), but 
we have yet to observe how DLL1, DDL3, and DDL4 transcript are affected by the MED12 
knockdown. If we determine that one of the five Notch ligands is significantly affected by 
the MED12 knockdown, either increased or decreased, the next objective will be to 
knockdown that specific ligand and work to determine the influence of that ligand on 
MED12, Notch1, or Notch3 expression and hASC self-renewal. We can also observe the 




potential role of non-canonical ligands, specifically DLK1 and DLK2, in controlling hASC 
self-renewal. Finally, in order to determine the global changes in gene expression following 
the knockdown of any one of these critical transcriptional regulatory, we could perform 
microarray analysis or RNA-Seq. Understanding of how we can control the fate of stem 










Allen, B. L. and Taatjes, D. J. (2015) “The Mediator complex: A central integrator 
of transcription,” Nature Reviews Molecular Cell Biology, 16(3), pp. 155–166. doi: 
10.1038/nrm3951. 
Daniel E Shumer, Natalie J Nokoff, N. P. S. (2017) “Key Transcription Factors in 
the Differentiation of Mesenchymal Stem Cells,” Physiology & behavior, 176(12), pp. 
139–148. doi: 10.1016/j.physbeh.2017.03.040. 
Fant, C. B. and Taatjes, D. J. (2019) “Regulatory functions of the Mediator kinases 
CDK8 and CDK19,” Transcription, 10(2), pp. 76–90. doi: 
10.1080/21541264.2018.1556915. 
Henrique, D. and Schweisguth, F. (2019) “Mechanisms of notch signaling: A 
simple logic deployed in time and space,” Development (Cambridge). doi: 
10.1242/dev.172148. 
Katoh, Masuko and Katoh, Masaru (2020) “Precision medicine for human cancers 
with Notch signaling dysregulation (Review),” International Journal of Molecular 
Medicine, 45(2), pp. 279–297. doi: 10.3892/ijmm.2019.4418. 
Knuesel, M. T. et al. (2009) “The Human CDK8 Subcomplex Is a Histone Kinase 
That Requires Med12 for Activity and Can Function Independently of Mediator,” 




Kopan, R. and Ilagan, M. X. G. (2009) “The Canonical Notch Signaling Pathway: 
Unfolding the Activation Mechanism,” Cell, pp. 216–233. doi: 10.1016/j.cell.2009.03.045. 
Leach, D. and Leach, D. (2017) “The Role Of Cyclin-Dependent Kinase 8 In 
Vascular Disease by.” 
Mead, B. et al. (2015) “Stem cell treatment of degenerative eye disease,” Stem Cell 
Research, 14(3), pp. 243–257. doi: 10.1016/j.scr.2015.02.003. 
Miana, V. V. and Prieto González, E. A. (2018) “Adipose tissue stem cells in 
regenerative medicine,” Ecancermedicalscience, 12, pp. 1–14. doi: 
10.3332/ecancer.2018.822. 
NITKIN, C. R. and BONFIEL, T. L. (2014) “Concise Review: Mesenchymal Stem 
Cell Therapy for Pediatric Disease: Perspectives on Success and Potential Improvements,” 
pp. 1–27. doi: 10.5966/sctm.2013-0207. 
Nueda, M. L. et al. (2018) “DLK proteins modulate NOTCH signaling to influence 
a brown or white 3T3-L1 adipocyte fate,” Scientific Reports, 8(1), pp. 1–16. doi: 
10.1038/s41598-018-35252-3. 
Park, M. J. et al. (2018) “Oncogenic exon 2 mutations in Mediator subunit MED12 
disrupt allosteric activation of cyclin C-CDK8/19,” Journal of Biological Chemistry, 
293(13), pp. 4870–4882. doi: 10.1074/jbc.RA118.001725. 
Sobhani, A. et al. (2017) “Multipotent stem cell and current application,” Acta 
Medica Iranica. Medical Sciences University of Teheran, pp. 6–23. 
Straub, J., Venigalla, S. and Newman, J. J. (2020) “Mediator’s Kinase Module: A 





Wu, B. et al. (2017) “MED12 mutations and NOTCH signalling in chronic 
lymphocytic leukaemia,” British Journal of Haematology, 179(3), pp. 421–429. doi: 
10.1111/bjh.14869. 
  
 
 
 
 
 
 
 
